KLK8 and non-small cell lung carcinoma: Both in vivo studies and clinical data from patients with NSCLC reveal that elevated KLK8 levels correlate with slower tumor growth, reduced invasion, and extended time to postoperative recurrence, particularly in early-stage cases (47).